HealthNet - All plan years
Skyrizi (150 MG Dose) (risankizumab-rzaa)
Drugs for the Skin : Drugs for the Skin
  • Step Therapy: Psoriasis (PsO):
    ST Single Generic

  • Prior Authorization: Psoriasis (PsO):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

  • Psoriasis (PsO):
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): 1 of Dermatologist;Rheumatologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 6 month(s)
    TB Test required: No
    History of Plaque Psoriasis: N/A
    Overall % of Body Surface For Initiation: N/A
    Overall % of Body Surface For Initiation With Sensitive Areas: N/A
    Psoriasis Classification: Unspecified
    Sensitive Area BSA Percent override: No